XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 5,990 $ 7,737
Trade receivables 134 200
Other accounts receivable and prepaid expenses 911 230
Inventory 355 175
Total current assets 7,390 8,342
Non-current assets:    
Fixed assets, net 5 5
Other assets 17 19
Severance pay fund 207 207
Operating lease right-of-use assets, net 44 49
Total non-current assets 273 280
Total assets 7,663 8,622
Current liabilities:    
Trade payables 172 87
Other accounts payable and accrued expenses 1,747 1,723
Deferred revenues 44 44
Operating lease liabilities - current 44 49
Total current liabilities 2,007 1,903
Non-current liabilities:    
Accrued severance pay 253 253
Deferred licensing income 142 153
Total liabilities 2,402 2,309
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Common stock of $0.001 par value - Authorized: 40,000,000 shares at March 31, 2022 and December 31, 2021, respectively; Issued and outstanding: 27,997,793 shares at March 31, 2022 and December 31, 2021, 28 28
Additional paid in capital 63,248 63,162
Accumulated other comprehensive income 54 60
Accumulated deficit (58,069) (56,937)
Total stockholders’ equity 5,261 6,313
Total liabilities and stockholders’ equity 7,663 8,622
Series C Preferred Stock [Member]    
Stockholders’ equity:    
Preferred stock, value
Series D Preferred Stock [Member]    
Stockholders’ equity:    
Preferred stock, value
Series E Preferred Stock [Member]    
Stockholders’ equity:    
Preferred stock, value